VistaGen welcomes new stem cell technique

H. Ralph Snodgress, president and CEO of South San Francisco’s VistaGen Therapeutics Inc., said he welcomed news of a discovery reported this week that allows adult skin cells to be reprogrammed into human universal cells.

While VistaGen uses embryonic stem cells in its work developing treatments for diabetes and neurological disorders, Snodgrass said the new technique would complement the company’s work.

“Any new discovery or technology that enables the generation of diverse embryonic stem cells, especially those unique to specific diseases, is very useful,” he said.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Emergency housing made available for domestic violence survivors

Victims of abuse who are trapped during lockdown may have somewhere to turn

Sunset supervisor wants to keep Great Highway car free during crisis

Mar eyes empty roadway as ideal space for bicylists and pedestrians

Future uncertain for San Francisco Pride 2020 amid coronavirus

Mayor Breed casts doubt on large-scale gathering being held during crisis

Most Read